These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9860151

  • 1. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M, Kotegawa T, Tsutsumi K, Nakamura K, Nakano S.
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [Abstract] [Full Text] [Related]

  • 2. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.
    Kamberi M, Tsutsumi K, Kotegawa T, Kawano K, Nakamura K, Niki Y, Nakano S.
    Antimicrob Agents Chemother; 1999 Mar; 43(3):525-9. PubMed ID: 10049262
    [Abstract] [Full Text] [Related]

  • 3. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S.
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [Abstract] [Full Text] [Related]

  • 4. High performance thin-layer chromatographic method for the determination of sparfloxacin in human plasma and its use in pharmacokinetic studies.
    Mody VD, Pandya KK, Satia MC, Modi IA, Modi RI, Gandhi TP.
    J Pharm Biomed Anal; 1998 Apr; 16(8):1289-94. PubMed ID: 9777602
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
    Zix JA, Geerdes-Fenge HF, Rau M, Vöckler J, Borner K, Koeppe P, Lode H.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1668-72. PubMed ID: 9257738
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.
    Montay G, Bruno R, Vergniol JC, Ebmeier M, Le Roux Y, Guimart C, Frydman A, Chassard D, Thebault JJ.
    J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Fillastre JP, Montay G, Bruno R, Etienne I, Dhib M, Vivier N, Le Roux Y, Guimart C, Gay G, Schott D.
    Antimicrob Agents Chemother; 1994 Apr; 38(4):733-7. PubMed ID: 8031038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of food on the pharmacokinetics of sparfloxacin.
    Johnson RD, Dorr MB, Hunt TL, Jensen BK, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):982-91. PubMed ID: 10440622
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cimetidine does not alter sparfloxacin pharmacokinetics.
    Gries JM, Honorato J, Taburet AM, Alvarez MP, Sadaba B, Azanza JR, Singlas E.
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):585-7. PubMed ID: 8688981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics.
    Neuvonen PJ, Kärkkäinen S.
    Clin Pharmacol Ther; 1983 Mar; 33(3):386-93. PubMed ID: 6297841
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.